Firm develops glucose sensing system for artificial pancreas

03/6/2012 | (U.K.)

Researchers at PositiveID have created a prototype of a fully synthetic artificial glucose sensing system that can detect and respond to glucose levels in human plasma. The advance could play a key role in developing an artificial pancreas for patients with type 1 diabetes, the company's chairman and CEO said.

View Full Article in: (U.K.)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Claims Director
Springfield, OR
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA